Crossmark

Investigation of circulating miR-182-3p, miR -382-3p and miR -93, miR -142-3p involved in tamoxifen resistance and sensitivity in luminal-subtype breast cancer patients: a case–control study

Crossref DOI link: https://doi.org/10.1007/s00210-024-03770-9

Published Online: 2025-01-04

Published Print: 2025-06

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Aboutalebi Vand Beilankouhi, Elmira

Sanaat, Zohreh

Hosseinpour Feizi, Mohammad Ali

Mehdizadeh, Amir

Safaralizadeh, Reza
License Information

Text and Data Mining valid from 2025-01-04

Version of Record valid from 2025-01-04
More Information

Article History

Received: 29 October 2024

Accepted: 26 December 2024

First Online: 4 January 2025

Declarations

:

: Written informed consent was obtained from each patient, and all study steps were explained to all participants prior to any action. This study was approved by the ethics committee of Tabriz University of Medical Sciences (Code: IR.TBZMED.REC.1402.022).

: The authors declare no competing interests.

Document is current

Any future updates will be listed below